SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Ron who wrote (455)2/4/1999 2:08:00 PM
From: Dr. John M. de Castro  Respond to of 1386
 
Food for thought!
I ran into this article referenced on another thread. But it seemed very appropriate considering what is happening to PARS. BTW I increased my stake in PARS by 40% today. I consider it stealing.

John de C

cbs.marketwatch.com



To: Ron who wrote (455)2/4/1999 5:33:00 PM
From: Richard Huth  Respond to of 1386
 
Ron,I share your reasons for staying long. If I wouldn't believe that PARS offers a good long term investment opportunity and owns an interesting portfolio, I would sell the share, not stay at a hold.

But the only thing that helps us are new investors, that buy the stock, and here I see a problem (as described).

But I do wish you a great success with PARS (not unselfish ;-) ).

Richard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News